JP2024518011A5 - - Google Patents

Info

Publication number
JP2024518011A5
JP2024518011A5 JP2023551146A JP2023551146A JP2024518011A5 JP 2024518011 A5 JP2024518011 A5 JP 2024518011A5 JP 2023551146 A JP2023551146 A JP 2023551146A JP 2023551146 A JP2023551146 A JP 2023551146A JP 2024518011 A5 JP2024518011 A5 JP 2024518011A5
Authority
JP
Japan
Prior art keywords
domain
antigen
receptor
mam
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023551146A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024518011A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/017177 external-priority patent/WO2022178367A2/en
Publication of JP2024518011A publication Critical patent/JP2024518011A/ja
Publication of JP2024518011A5 publication Critical patent/JP2024518011A5/ja
Pending legal-status Critical Current

Links

JP2023551146A 2021-02-19 2022-02-21 多様な免疫細胞のための単鎖および多鎖合成抗原受容体 Pending JP2024518011A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163151421P 2021-02-19 2021-02-19
US63/151,421 2021-02-19
US202163245181P 2021-09-16 2021-09-16
US63/245,181 2021-09-16
PCT/US2022/017177 WO2022178367A2 (en) 2021-02-19 2022-02-21 Single-chain and multi-chain synthetic antigen receptors for diverse immune cells

Publications (2)

Publication Number Publication Date
JP2024518011A JP2024518011A (ja) 2024-04-24
JP2024518011A5 true JP2024518011A5 (cg-RX-API-DMAC7.html) 2025-04-10

Family

ID=82932320

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023551146A Pending JP2024518011A (ja) 2021-02-19 2022-02-21 多様な免疫細胞のための単鎖および多鎖合成抗原受容体

Country Status (8)

Country Link
US (1) US20240390496A1 (cg-RX-API-DMAC7.html)
EP (1) EP4297769A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024518011A (cg-RX-API-DMAC7.html)
KR (1) KR20230153529A (cg-RX-API-DMAC7.html)
AU (1) AU2022224066A1 (cg-RX-API-DMAC7.html)
CA (1) CA3208717A1 (cg-RX-API-DMAC7.html)
IL (1) IL305175A (cg-RX-API-DMAC7.html)
WO (1) WO2022178367A2 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190016802A1 (en) 2017-07-14 2019-01-17 Immatics Biotechnologies Gmbh Dual specificity polypeptide molecule
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
KR20210124308A (ko) 2019-01-30 2021-10-14 트루바인딩 아이엔씨. 항-gal3 항체 및 이의 용도
KR20220149606A (ko) * 2020-03-02 2022-11-08 더 리전츠 오브 더 유니버시티 오브 캘리포니아 암 치료를 위한 키메라 항원 수용체 및 관련 방법 및 조성물
WO2021188599A1 (en) * 2020-03-16 2021-09-23 University Of Southern California Novel antigen binding domains and synthetic antigen receptors incorporating the same
MX2022014786A (es) 2020-05-26 2023-01-16 Truebinding Inc Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3.
KR20240004937A (ko) 2021-05-05 2024-01-11 이매틱스 바이오테크놀로지스 게엠베하 Bma031 항원 결합 폴리펩타이드
WO2022233956A1 (en) 2021-05-05 2022-11-10 Immatics Biotechnologies Gmbh Antigen binding proteins specifically binding prame
AR130387A1 (es) * 2022-09-08 2024-12-04 Hoffmann La Roche Receptores de linfocitos t recombinantes
CN116514992B (zh) * 2022-11-07 2024-05-24 武汉波睿达生物科技有限公司 一种信号肽序列优化的靶向cd19的嵌合抗原受体及其应用
WO2024102954A1 (en) * 2022-11-10 2024-05-16 Massachusetts Institute Of Technology Activation induced clipping system (aics)
JP2026501516A (ja) * 2023-01-05 2026-01-16 アンヘレス セラピューティクス インコーポレイテッド 遺伝子導入および合成および免疫受容体の活性を制御するための方法および組成物
SE548109C2 (en) * 2023-03-28 2026-03-30 Cerimmune Therapeutics Ab Microglial endocytic receptors for use in the treatment of neurodegenerative disease
PE20260290A1 (es) * 2023-03-31 2026-02-10 Abelzeta Inc Receptores de antigeno quimericos biespecificos dirigidos a cd20 y bcma
CN121620592A (zh) * 2023-05-01 2026-03-06 西雅图儿童医院d/b/a西雅图儿童研究所 表达突变体白细胞介素15的免疫细胞
EP4712986A1 (en) * 2023-05-18 2026-03-25 A2 Biotherapeutics, Inc. Immune cells with paired receptors and uses thereof
JP2026526219A (ja) * 2023-07-28 2026-08-06 エヌケーアイエルティー セラピューティクス インコーポレイテッド キメラilt受容体組成物および方法
WO2025067318A1 (zh) * 2023-09-28 2025-04-03 沛尔生技医药股份有限公司 具有细胞内信号传导结构域及自然杀伤蛋白30跨膜结构域的核酸分子及包含其的嵌合抗原受体
WO2025193475A1 (en) * 2024-03-14 2025-09-18 The Regents Of The University Of California Enhancing immune cell innate and adaptive responses
WO2025194049A1 (en) * 2024-03-15 2025-09-18 Dana-Farber Cancer Institute, Inc. Engineered immune cells and methods of using the same
WO2025235862A1 (en) * 2024-05-10 2025-11-13 Inndura Therapeutics Inc. A modified immune cell receptor comprising a target-binding domain and the extracellular domain of cd16a
TW202617750A (zh) * 2024-07-10 2026-05-01 美商安吉利斯治療學公司 包含表位與多肽的組成物及方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1131425A2 (en) * 1998-11-18 2001-09-12 Incyte Pharmaceuticals, Inc. Inflammation-associated genes
EP1882392A4 (en) * 2005-05-10 2009-07-01 Monsanto Technology Llc GENES AND THEIR USES FOR PLANT IMPROVEMENTS
US9833476B2 (en) * 2011-08-31 2017-12-05 The Trustees Of Dartmouth College NKP30 receptor targeted therapeutics
SG10201806573TA (en) * 2012-05-25 2018-09-27 Cellectis Methods for engineering allogeneic and immunosuppressive resistant t cell for immunotherapy
US20150017136A1 (en) * 2013-07-15 2015-01-15 Cellectis Methods for engineering allogeneic and highly active t cell for immunotherapy
AU2013312838B2 (en) * 2012-09-04 2018-11-29 Cellectis Multi-chain chimeric antigen receptor and uses thereof
US10093701B2 (en) * 2012-09-07 2018-10-09 University Of Miami Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof
CA2912375C (en) * 2013-05-13 2023-03-14 Cellectis Methods for engineering highly active t cell for immunotherapy
SI2997141T1 (sl) * 2013-05-13 2023-04-28 Cellectis CD19 specifični himerni antigenski receptor in njegova uporaba
AU2015292744C1 (en) * 2014-07-21 2021-01-21 Novartis Ag Treatment of cancer using humanized anti-BCMA chimeric antigen receptor
CN114533867A (zh) * 2015-03-27 2022-05-27 免疫生物公司 用于治疗癌症的被遗传修饰的nk-92细胞和单克隆抗体
EP3390645B1 (en) * 2016-02-23 2022-09-14 Salk Institute for Biological Studies Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
CN110352068A (zh) * 2016-12-02 2019-10-18 南加利福尼亚大学 合成的免疫受体及其使用方法
CN108728465A (zh) * 2017-04-14 2018-11-02 深圳新诺微环生物科技有限公司 一种表达靶细胞-效应细胞桥接器的微环dna载体及其制备方法和应用
SG11202008568WA (en) * 2018-03-09 2020-10-29 Sorrento Therapeutics Inc Dimeric antigen receptors (dar)
KR102907902B1 (ko) * 2018-08-01 2026-01-02 난트퀘스트, 인크. 면역 요법의 안정한 유전적 변형을 위한 귀소 수용체 또는 사이토카인, 및 키메라 항원 수용체를 포함하는 4 시스트론 시스템

Similar Documents

Publication Publication Date Title
JP2023518049A5 (cg-RX-API-DMAC7.html)
US20240390496A1 (en) Single-chain and multi-chain synthetic antigen receptors for diverse immune cells
IL273201B1 (en) Novel platforms for co-stimulation, novel car designs and other enhancements for adoptive cellular therapy
JP2020500530A5 (cg-RX-API-DMAC7.html)
AU2021307614B2 (en) Engineered immune cell for allotransplantation
JP2019525956A5 (cg-RX-API-DMAC7.html)
US11760806B2 (en) CD-38 directed chimeric antigen receptor constructs
JP2021532742A5 (cg-RX-API-DMAC7.html)
CN113271953B (zh) 细胞免疫治疗的组合
JP2021500861A5 (cg-RX-API-DMAC7.html)
JP2019518424A5 (cg-RX-API-DMAC7.html)
JP2017513818A5 (cg-RX-API-DMAC7.html)
US20220389075A1 (en) Engineered t cell receptors and uses thereof
CA3032054A1 (en) Combination therapies of chimeric antigen receptors and pd-1 inhibitors
JP2023549098A5 (cg-RX-API-DMAC7.html)
JP2023530704A5 (cg-RX-API-DMAC7.html)
JP2021514631A5 (cg-RX-API-DMAC7.html)
WO2020057641A1 (zh) 表达有趋化因子的细胞及用途
JP2023525720A5 (cg-RX-API-DMAC7.html)
EP3822345A1 (en) Genetically engineered cell and application thereof
IL297514A (en) Vectors and methods for in vivo transduction
WO2021030153A2 (en) Engineered t cell receptors and uses thereof
JP2023548829A5 (cg-RX-API-DMAC7.html)
JP2024510900A5 (cg-RX-API-DMAC7.html)
JP2024515920A5 (cg-RX-API-DMAC7.html)